SciELO - Scientific Electronic Library Online

 
vol.71 issue3Regarding a case of Chikungunya fever imported from AmericaPrevention and infection control to suspected cases of infection with the new coronavirus MERS-CoV in military units author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Sanidad Militar

Print version ISSN 1887-8571

Abstract

APARICIO HERNANDEZ, R.; GARCIA LUQUE, A.; PEREZ MORAN, M.J.  and  SANCHEZ LOPEZ, P.. Possitive assesment of drugs: march, April and May 2015. Sanid. Mil. [online]. 2015, vol.71, n.3, pp.186-195. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712015000300006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in March, April and May of 2015, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Keywords : Atazanavir / Cobicistat; Evotaz®; Cloruro de lutecio; 177LU; Lumark®; Dinutuxima; Unituxin®; Edoxaban; Lixiana®; Empagliflozina/metformina; Synjardy®; Evolocumab; Repatha®; Fenilefrina / ketorolaco; Omidria®; Lenvatinib; Lenvima®; Netupitant/ palonosetron; Akynzeo®; Nivolumab; Opdivo®; Nivolumab; Nivolumab BMS®; Pembrolizumab; Keytruda®; Tasimelteon; Hetlioz®; Vacuna frente al virus del papiloma humano nonavalente; Gardasil 9®.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License